Bausch + Lomb Corporation

13.82
1.08 (8.48%)
At close: Apr 24, 2025, 3:59 PM
13.89
0.51%
After-hours: Apr 24, 2025, 04:05 PM EDT
8.48%
Bid 11.9
Market Cap 4.88B
Revenue (ttm) 4.79B
Net Income (ttm) -445M
EPS (ttm) -0.92
PE Ratio (ttm) -15.02
Forward PE 13.88
Analyst Hold
Ask 14
Volume 572,884
Avg. Volume (20D) 725,250
Open 13.13
Previous Close 12.74
Day's Range 13.11 - 13.83
52-Week Range 10.46 - 21.69
Beta 0.54

About BLCO

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral...

Sector Healthcare
IPO Date May 6, 2022
Employees 13,500
Stock Exchange NYSE
Ticker Symbol BLCO
Full Company Profile

Analyst Forecast

According to 11 analyst ratings, the average rating for BLCO stock is "Hold." The 12-month stock price forecast is $18, which is an increase of 30.25% from the latest price.

Stock Forecasts

Next Earnings Release

Bausch + Lomb Corporation is scheduled to release its earnings on Apr 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-9.52%
Bausch + Lomb shares are trading lower after the c... Unlock content with Pro Subscription
4 months ago
-12.06%
Bausch + Lomb shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $24 to $22.